Table 1.
Detailed clinical information of the HS and PD patient-derived fibroblasts used in the current study
| Cell ID | Description | Sex | Age at biopsy |
|---|---|---|---|
| HS10 | Healthy subject | F | 68 |
| HS11 | Healthy subject | F | 60 |
| HS17 | Healthy subject | F | 62 |
| HS18 | Healthy subject | F | 65 |
| HS20 | Healthy subject | M | 66 |
| HS21 | Healthy subject | M | 66 |
| HS22 | Healthy subject | F | 61 |
| HS23 | Healthy subject | F | 76 |
| HS24 | Healthy subject | M | 67 |
| HS25 | Healthy subject | M | 61 |
| HS26 | Healthy subject | M | 66 |
| HS29 | Healthy subject | M | 66 |
| HS30 | Healthy subject | M | 67 |
| PD4 | LRRK2 G2019S | Not documented | Not documented |
| PD12 | LRRK2 G2019S | M | 72 |
| PD13 | LRRK2 G2019S | M | 57 |
| PD16 | LRRK2 G2019S | M | 52 |
| PD20 | LRRK2 G2019S | M | 73 |
| PD23 | LRRK2 G2019S | Not documented | Not documented |
| PD28 | LRRK2 G2019S homo. | M | 77 |
| PD29 | LRRK2 G2019S | M | 36 |
| PD36 | LRRK2 G2019S homo. | M | 55 |
| PD37 | LRRK2 G2019S homo. | M | 74 |